Ypsomed
Michael Rogge is a seasoned professional in quality management and assurance with extensive experience across various roles in the industry. Currently serving as Manager Quality Control and Manager Test Equipment at Ypsomed AG since April 2017, Michael is responsible for overseeing quality control processes and the management of test equipment. Previously, roles at mollet AG included Qualitäts- und Prozessmanager, where Michael coordinated quality management system improvements and managed training and audits. Prior experience includes positions at Sintron-Polymec AG, Stryker, and Bosch, focusing on quality and measurement techniques. Michael holds qualifications in quality and process management and process validation in medical devices from SAQ Qualicon and TÜV Süd Akademie, respectively.
Ypsomed
4 followers
Ypsomed Holding AG is a Switzerland-based holding company engaged in the manufacture of injection pens for pharmaceutical and biotech companies. The Company develops and manufactures injection systems for custom-made self-administration, and markets pen needles for the treatment of diabetes, growth disorders or infertility, as well as therapeutic areas. The Company operates two business segments: Injection Systems and Diabetes Care. In the Injection Systems segment, the Company's YDS Ypsomed Delivery Systems offer a range of ready-to-use injection systems for pharmaceutical and biotech companies to administer of drugs or to develop and manufacture them in line with customer requirements. The Diabetes Care segment markets products such as pen needles or insulin pump to diabetics, doctors and health insurance providers. The Company operates its production sites in Burgdorf, Solothurn, Grenchen and Tabor, and sales and distribution network across Europe.